Yasmin Hurd
Yasmin Hurd | |
|---|---|
| Alma mater | Binghamton University, Karolinska Institutet |
| Scientific career | |
| Fields | Neuroscience, Neurobiology of Addiction |
| Institutions | Icahn School of Medicine at Mount Sinai |
Yasmin Hurd is an American professor of Neuroscience, Psychiatry, and Pharmacology and Systems Therapeutics at the Icahn School of Medicine at Mount Sinai in New York City.[1] She is also the former director of the medical school's combined MD/PhD Medical Scientist Training Program.[2] She completed her PhD at the Karolinska Institutet in Stockholm, Sweden, where her work with microdialysis led to advances in neuropharmacology.[3] Her work has been cited more than 5,000 times, and she has an H-Index of 39.[4]
Her work on the neurobiology of addiction, especially with regard to developmental changes caused by cannabis, has been profiled in a variety of popular news sources.[5][6][7][8][9][10]
References
- ^ "Yasmin Hurd - Icahn School of Medicine at Mount Sinai". Icahn School of Medicine at Mount Sinai. Retrieved 25 November 2014.
- ^ [1] [dead link]
- ^ "Faces of Drug Abuse Research: Yasmin L Hurd, Ph.D." DrugMonkey. Retrieved 25 November 2014.
- ^ "Scopus - Cookies Disabled". Scopus.com. Retrieved 25 November 2014.
- ^ "Pot is not 'more dangerous than alcohol'? Science lacking on Obama's claim". Boston.com. Retrieved 25 November 2014.
- ^ Dr. Yasmin Hurd. "Dangerous Substance" (PDF). Icahn.mssm.edu. Retrieved 25 November 2014.
- ^ "Cannabis Effects Visit Sons Unto the 3rd Generation". Medpagetoday.com. 14 November 2013. Retrieved 25 November 2014.
- ^ "Yasmin Hurd". Newyork.cbslocal.com. Retrieved 25 November 2014.
- ^ "Reefer madness: neurologist Professor Yasmin Hurd". sixtyminutes. Retrieved 25 November 2014.
- ^ BCRP - Chantal Pesant. "Perception of marijuana as a "safe drug" is scientifically inaccurate". Nouvelles.umontreal.ca. Retrieved 25 November 2014.